ACR 2022 Tweet by Catherine Sims, MD

Tweet
Catherine Sims, MD @DrCassySims Nov 13, 2022
View on
🧨Late breaking abstract🧨 #ACR22 @RheumNow #ACRbest

Identifying fetal myocardial targets in congenital heart block (CHB)

Abstract #L13

🫀maternal serum underwent mass spec. that identified Ab to 4 protein targets that predicted CHB including anti-ATP1A1 as early as 7w

Related Content

Podcast

DERM on RheumNow PODCAST (September 2026)

RheumNow Sep 30, 2026
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, calcinosis, CTD skin disorders. dermatology drugs, biologics, and JAK inhibitors. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: FDA Grants Priority…
Article Education/ACR/EULAR

Remission – Believe it or Not (10.2.2026)

Jack Cush, MD Oct 2, 2026
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.Upadacitinib is now approved in European Union to treat active polyarticular juvenile idiopathic arthritis (pJIA) ages > 2yrs for those not responding to 1+ DMARDs. In the USA, UPA is approved for pJIA &…
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×